High-density lipoprotein impedes glycation of low-density lipoprotein

Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages

(2011) Fatiha Tabet et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL

(2011) Sara Elsøe et al.   ATHEROSCLEROSIS

Metabolic and functional relevance of HDL subspecies

(2011) Bela F Asztalos et al.   CURRENT OPINION IN LIPIDOLOGY

Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity: A Possible Contributor to Increased Risk of Cardiovascular Disease in Diabetes

(2011) N. Rabbani et al.   DIABETES

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

(2011) Christian Besler et al.   JOURNAL OF CLINICAL INVESTIGATION

Triglyceride–high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus

(2011) Giacomo Zoppini et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

(2011) Mohamad Navab et al.   Nature Reviews Cardiology

Oxidized Low-Density Lipoprotein and Atherosclerosis

(2010) Daniel Steinberg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes

(2010) Nahla N Younis et al.   Diabetes & Vascular Disease Research

Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins

(2009) Pia Davidsson et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Human Paraoxonase Gene Cluster Transgenic Overexpression Represses Atherogenesis and Promotes Atherosclerotic Plaque Stability in ApoE-Null Mice

(2009) Zhi-Gang She et al.   CIRCULATION RESEARCH

Lipoprotein glycation in atherogenesis

(2009) Nahla N Younis et al.   Clinical Lipidology

Variation in paraoxonase-1 activity and atherosclerosis

(2009) Handrean Soran et al.   CURRENT OPINION IN LIPIDOLOGY

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes

(2009) Philip W. Connelly et al.   JOURNAL OF LIPID RESEARCH

Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy

(2009) CHENGJIANG LI et al.   NEPHROLOGY

Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study

(2009) Rakesh S. Birjmohun et al.   PLoS One

Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes

(2008) Yukio Ikeda et al.   ACTA DIABETOLOGICA

Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women

(2008) Thomas M. van Himbergen et al.   ATHEROSCLEROSIS

Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro

(2008) Nahla Younis et al.   ATHEROSCLEROSIS

High-density lipoproteins, inflammation and oxidative stress

(2008) Fatiha Tabet et al.   CLINICAL SCIENCE

Glycation as an atherogenic modification of LDL

(2008) Nahla Younis et al.   CURRENT OPINION IN LIPIDOLOGY

Association Between p.Leu54Met Polymorphism at the Paraoxonase-1 Gene and Plantar Fascia Thickness in Young Subjects With Type 1 Diabetes

(2008) P. H. Gallego et al.   DIABETES CARE

Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular Risk

(2008) Tamali Bhattacharyya   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: The PRIME study

(2007) J.A. Troughton et al.   ATHEROSCLEROSIS